Kailera Therapeutics Files for IPO to Fund Obesity Drugs
Kailera Therapeutics has announced its application for an initial public offering (IPO) in the United States to raise funds for developing a range of obesity treatments. This move comes as the global demand for effective solutions to combat the obesity crisis continues to rise.